The recipients of
Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical) which
supports "emerging research" that will drive the development of dermatology, have been decided.
April 1, 2025
ROHTO Pharmaceutical Co., Ltd. (Head office: Osaka; Representative: Masashi Sugimoto) has established and operated "Rohto Dermatological Research Fund" since 2008 for the purpose of contributing to the improvement and development of dermatology, and has been jointly operating "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" with Japanese Dermatological Association (hereinafter Japanese Dermatological Association), a public interest incorporated association, since the selection of recipients for fiscal 2025.
We are pleased to announce that two recipients for FY2025 have been selected from "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)".
About Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)
The Dermatological Research Fund (Endowment by Rohto Pharmaceutical) provides research funding for innovative and pioneering basic research that is expected to make a significant contribution to the future development of dermatology. Two recipients will each receive a research grant of 3 million yen to conduct two years of research.
Recipients of Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical) in 2020
| Name |
Affiliation |
Research topic |
| Mika Watanabe |
Hokkaido University |
Elucidation of stem cell memory and skin homeostasis through wound and metabolism |
| Mr. Satoshi Nakamizo |
Kyoto University |
Comprehensive analysis of environmental stress responses in atopic dermatitis |
(In alphabetical order by branch of Japanese Dermatological Association)